11
Participants
Start Date
November 18, 2024
Primary Completion Date
June 13, 2028
Study Completion Date
March 31, 2033
Alectinib
"Cohort B1: participants will receive oral alectinib twice daily (BID) for up to 5 years.~Cohort B2: Participants will receive oral alectinib BID for 3 cycles (cycle length = 3 weeks) prior to surgery, and for up to 5 years after surgery."
Cisplatin
"Cohort B1: Participants will receive intravenous (IV) cisplatin on Day 1 of each cycle for up to 4 cycles (cycle length = 3 weeks).~Cohort B2: Participants will receive IV cisplatin on Day 1 of each cycle for up to 3 cycles (cycles length = 3 weeks) prior to surgery."
Carboplatin
"Cohort B1: Participants will receive IV carboplatin on Day 1 of each cycle for up to 4 cycles (cycle length = 3 weeks).~Cohort B2: Participants will receive IV carboplatin on Day 1 of each cycle for up to 3 cycles (cycle length = 3 weeks) prior to surgery."
Pemetrexed
"Cohort B1: Participants will receive IV pemetrexed on Day 1 of each cycle for up to 4 cycles (cycle length = 3 weeks).~Cohort B2: Participants will receive IV pemetrexed on Day 1 of each cycle for up to 3 cycles (cycle length = 3 weeks) prior to surgery."
Auckland City Hospital, Cancer and Blood Research, Auckland
Royal North Shore Hospital, St Leonards
Sir Charles Gairdner Hospital, Nedlands
Oncology Unit, Faculty of Medicine, Vajira Hospital, Dusit
Faculty of Med. Siriraj Hosp., Bangkok
Clinical Research Alliance, Westbury
CHU Timone, Marseille
St. Vincent's Hospital, Gyeonggi-do
Hospital Regional Universitario Carlos Haya, Málaga
CHU de Bordeaux, Pessac
Baptist Cancer Center, Memphis
Srinagarind Hospital, Khon Kaen
Maharaj Nakorn Chiang Mai Hosp, Chang Mai
CHU Strasbourg - Nouvel Hopital Civil, Strasbourg
Centre Leon Berard, Lyon
University of Colorado Anschutz Medical Campus, Aurora
Beijing Cancer Hospital, Beijing
Xiangya Hospital of Centre-South University, Changsha
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan
Guangdong General Hospital, Guangzhou
Yunnan Cancer Hospital, Kunming
Universidade de Caxias do Sul - Rio Grande do Sul, Caxias do Sul
Hospital de Clínicas de Porto Alegre X, Porto Alegre
Hospital Sao Lucas - PUCRS, Porto Alegre
Hospital de Cancer de Barretos, Barretos
Hospital de Base de Sao Jose do Rio Preto, São José do Rio Preto
Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo
RedSalud Vitacura, Santiago
The third people's hospital of Chengdu, Chengdu
Jinhua municipal central hospital, Jinhua
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia, Perugia
Centro Oncologico Internacional, Mexico City
ARKE Estudios Clínicos S.A. de C.V., Mexico City
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Hoffmann-La Roche
INDUSTRY